Model
Edge
Citius Pharmaceuticals Inc.
CTXR
Filing Type
S-3
Filing Date
5/21/2026
Updated
5/22/26, 3:00 PM
Filing
S-3
Earnings Release
Exhibits
S-3
Registration Statement for Securities Offered under a Shelf Registration
EX-5.1
OPINION OF WYRICK ROBBINS YATES & PONTON LLP
EX-23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic